Please login to the form below

Not currently logged in

Bluebird Bio reveals further encouraging data for CALD gene therapy

Bluebird BioStudy shows continued benefit in treatment of rare disease

Distribution of Novartis’ generic Zantac halted due to carcinogen concerns

Sandoz NovartisRanitidine medicines found to contain cancer-causing substance

Takeda’s HAE drug Takhzyro backed by NICE

New treatment option for rare, hereditary disease

Biogen loses another pipeline drug to toxicity concerns

BiogenFollows discontinuation of Eisai-partnered Alzheimer's drug

Jessica Pacey 2

Q&A: Jessica Pacey

PME interviews the founder and chief executive of newly launched health comms agency, 67health

EU flag body

Who's calling the shots in European healthcare?

Patients versus Pharma: industry too powerful, and too cosy with EMA, says Yannis Natsis

The Gallery

A visual showcase of agency work. Track down an agency from the image, track down your competitors' work, search by product or therapy area to pull up, for example, cardiovascular campaigns. Click here for a portfolio of hundreds of campaign visuals – updated regularly – free for you to reference. Agencies – to add your work to The Gallery please contact us.

Breaking free

Pharma’s ability to understand and modify customer behaviour is improving – but is it doing enough?

Breaking free PME sept

Life announces two new hires

Strenghtens growing creative department

Life new hires

Unlocking the potential of science and technology in the UK

Greater collaboration is vital in post-Brexit UK, says Alderley Park leader

Trust: the ultimate elevator

By Andreas Reinbolz, Daniel Schäfer and Ralf Steinmetz

Syneos TL authors

Featured jobs

Subscribe to our email news alerts


Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...